Style | Citing Format |
---|---|
MLA | Mirzaei R, et al.. "The Emerging Role of Micrornas in the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection." International Immunopharmacology, vol. 90, no. , 2021, pp. -. |
APA | Mirzaei R, Mahdavi F, Badrzadeh F, Hosseinifard SR, Heidary M, Jeda AS, Mohammadi T, Roshani M, Yousefimashouf R, Keyvani H, Darvishmotevalli M, Sani MZ, Karampoor S (2021). The Emerging Role of Micrornas in the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection. International Immunopharmacology, 90(), -. |
Chicago | Mirzaei R, Mahdavi F, Badrzadeh F, Hosseinifard SR, Heidary M, Jeda AS, Mohammadi T, et al.. "The Emerging Role of Micrornas in the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection." International Immunopharmacology 90, no. (2021): -. |
Harvard | Mirzaei R et al. (2021) 'The Emerging Role of Micrornas in the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection', International Immunopharmacology, 90(), pp. -. |
Vancouver | Mirzaei R, Mahdavi F, Badrzadeh F, Hosseinifard SR, Heidary M, Jeda AS, et al.. The Emerging Role of Micrornas in the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection. International Immunopharmacology. 2021;90():-. |
BibTex | @article{ author = {Mirzaei R and Mahdavi F and Badrzadeh F and Hosseinifard SR and Heidary M and Jeda AS and Mohammadi T and Roshani M and Yousefimashouf R and Keyvani H and Darvishmotevalli M and Sani MZ and Karampoor S}, title = {The Emerging Role of Micrornas in the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection}, journal = {International Immunopharmacology}, volume = {90}, number = {}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Mirzaei R AU - Mahdavi F AU - Badrzadeh F AU - Hosseinifard SR AU - Heidary M AU - Jeda AS AU - Mohammadi T AU - Roshani M AU - Yousefimashouf R AU - Keyvani H AU - Darvishmotevalli M AU - Sani MZ AU - Karampoor S TI - The Emerging Role of Micrornas in the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection JO - International Immunopharmacology VL - 90 IS - SP - EP - PY - 2021 ER - |